Cargando…
Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991072/ http://dx.doi.org/10.1186/2051-1426-1-S1-O8 |
_version_ | 1782312376978112512 |
---|---|
author | Spranger, Stefani Gajewski, Thomas |
author_facet | Spranger, Stefani Gajewski, Thomas |
author_sort | Spranger, Stefani |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3991072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39910722014-05-01 Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment Spranger, Stefani Gajewski, Thomas J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991072/ http://dx.doi.org/10.1186/2051-1426-1-S1-O8 Text en Copyright © 2013 Spranger and Gajewski; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Spranger, Stefani Gajewski, Thomas Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title | Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title_full | Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title_fullStr | Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title_full_unstemmed | Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title_short | Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment |
title_sort | therapeutic efficacy of combined blockade of ctla-4 +/- pd-l1 +/- ido is associated with re-activation of t cells directly within the tumor microenvironment |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991072/ http://dx.doi.org/10.1186/2051-1426-1-S1-O8 |
work_keys_str_mv | AT sprangerstefani therapeuticefficacyofcombinedblockadeofctla4pdl1idoisassociatedwithreactivationoftcellsdirectlywithinthetumormicroenvironment AT gajewskithomas therapeuticefficacyofcombinedblockadeofctla4pdl1idoisassociatedwithreactivationoftcellsdirectlywithinthetumormicroenvironment |